Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Neurology|March 27, 2025
Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma NetworkHugo Hernández-Tost, Nicolas Weiss, Sylvain Choquet, et al.
Brain Communications|June 30, 2023
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicityAntonio Farina, Cristina Birzu, Mad-Hélénie Elsensohn, et al.
Journal of Neurology|February 17, 2026
Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapyCharleen Robert, Dimitri Psimaras, Sylvain Choquet, et al.
The Lancet Regional Health. Europe|August 22, 2024
Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort studyAntonio Farina, Macarena Villagrán-García, Anthony Fourier, et al.
Rheumatology (Oxford, England)|March 16, 2021
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre studyAmandine Weill, Julie Delyon, Vincent Descamps, et al.
Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicityGuido Cavaletti, David R Cornblath, Ingemar S J Merkies, et al.
Annals of Neurology|August 28, 2023
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABAB R and Anti-Hu Paraneoplastic Neurological SyndromesAlberto Vogrig, Antoine Pegat, Macarena Villagrán-García, et al.
European Journal of Neurology|March 20, 2026
Multiple Mononeuropathy Secondary to Parvovirus B19 Infection: A Case SeriesJulian Theuriet, Maud Michaud, Guillaume Fargeot, et al.
Biomedicines|June 28, 2023
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis-A Systematic ReviewAgustí Alentorn, Giulia Berzero, Harry Alexopoulos, et al.
The Lancet Regional Health. Europe|February 3, 2025
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort studyLotta Plomp, Hortense Chassepot, Dimitri Psimaras, et al.
Pageof 14